Comparison between A G Universal IPO and Sotac Pharmaceuticals IPO.
A G Universal IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Sotac Pharmaceuticals IPO is a SME Bookbuilding proposed to list at NSE SME.
| A G Universal IPO | Sotac Pharmaceuticals IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Share India Capital Services Pvt.Ltd. | Beeline Capital Advisors Pvt.Ltd. |
| Registrar | Skyline Financial Services Pvt.Ltd. | Kfin Technologies Ltd. |
| Market Maker | Share India Securities Ltd. | Sunflower Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of A G Universal IPO is up to ₹8.28 Cr whereas the issue size of the Sotac Pharmaceuticals IPO is up to ₹31.64 Cr. The final issue price of A G Universal IPO is ₹60.00 per share and of Sotac Pharmaceuticals IPO is ₹111.00 per share.
| A G Universal IPO | Sotac Pharmaceuticals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹105.00 per share | |
| Issue Price (Upper) | ₹111.00 per share | |
| Issue Price (Final) | ₹60.00 per share | ₹111.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 1200 shares |
| Fresh Issue Size | 13,80,000 shares | 28,50,000 shares |
| Fresh Issue Size (Amount) | up to ₹8.28 Cr | up to ₹31.64 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 13,80,000 shares | 28,50,000 shares |
| Issue Size Total (Amount) | up to ₹8.28 Cr | up to ₹31.64 Cr |
A G Universal IPO opens on Apr 11, 2023, while Sotac Pharmaceuticals IPO opens on Mar 29, 2023. The closing date of A G Universal IPO and Sotac Pharmaceuticals IPO is Apr 13, 2023, and Apr 03, 2023, respectively.
| A G Universal IPO | Sotac Pharmaceuticals IPO | |
|---|---|---|
| Anchor Bid Date | Mar 28, 2023 | |
| Issue Open | Apr 11, 2023 | Mar 29, 2023 |
| Issue Close | Apr 13, 2023 | Apr 03, 2023 |
| Basis Of Allotment (Tentative) | Apr 19, 2023 | Apr 10, 2023 |
| Initiation of Refunds (Tentative) | Apr 20, 2023 | Apr 11, 2023 |
| Credit of Share (Tentative) | Apr 21, 2023 | Apr 12, 2023 |
| Listing date (Tentative) | Apr 24, 2023 | Apr 13, 2023 |
| Anchor Lockin End date 1 | May 10, 2023 | |
| Anchor Lockin End date 2 | Jul 09, 2023 |
A G Universal IPO P/E ratio is 3.12, as compared to Sotac Pharmaceuticals IPO P/E ratio of 132.14.
| A G Universal IPO | Sotac Pharmaceuticals IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 95.53 | 84.63 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 70.20 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 3.12 | 132.14 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹32.90 Cr. | ₹122.66 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 39.79 | 53.1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 13.49 | 68.34 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.41 | 1.12 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹5.07 | ₹3.58 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 16.91 | 43.47 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the A G Universal IPO Retail Individual Investors (RII) are offered 6,90,000 shares while in Sotac Pharmaceuticals IPO retail investors are offered 6,90,000 shares. Qualified Institutional Buyers (QIB) are offered in A G Universal IPO and 5,70,000 shares in Sotac Pharmaceuticals IPO.
| A G Universal IPO | Sotac Pharmaceuticals IPO | |
|---|---|---|
| Anchor Investor Reservation | 8,53,200 shares | |
| Market Maker Reservation | 74,000 shares | 1,50,000 shares |
| QIB | 5,70,000 shares | |
| NII | 6,90,000 shares | 4,28,400 shares |
| RII | 6,90,000 shares | 9,98,400 shares |
| Employee | ||
| Others | ||
| Total | 13,80,000 shares | 28,50,000 shares |
A G Universal IPO subscribed 3.36x in total, whereas Sotac Pharmaceuticals IPO subscribed 1.60x.
| A G Universal IPO | Sotac Pharmaceuticals IPO | |
|---|---|---|
| QIB (times) | 1.00x | |
| NII (times) | 3.71x | 4.04x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 2.54x | 0.91x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 3.36x | 1.60x |
